相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Virotherapy as an approach against cancer stem cells
Camilla Ribacka et al.
CURRENT GENE THERAPY (2008)
Gene therapy progress and prospects cancer: oncolytic viruses
T-C Liu et al.
GENE THERAPY (2008)
Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus
M. Raki et al.
GENE THERAPY (2007)
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses
Kilian Guse et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Vascular endothelial growth factor trap in non-small cell lung cancer
GregoryJ. Riely et al.
CLINICAL CANCER RESEARCH (2007)
Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer
Tuuli Ranki et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cancer selective adenoviruses
Ramon Alemany
MOLECULAR ASPECTS OF MEDICINE (2007)
Clinical trials with oncolytic adenovirus in China
Wang Yu et al.
CURRENT CANCER DRUG TARGETS (2007)
A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta 24, for the treatment of advanced breast cancer
T. Ranki et al.
GENE THERAPY (2007)
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells
Gerd J. Bauerschmitz et al.
MOLECULAR THERAPY (2006)
Infectivity-enhanced Adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer
Lotta Kangasniemi et al.
CLINICAL CANCER RESEARCH (2006)
Hypoxic induction of an HIF-1α-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells
M Calvani et al.
BLOOD (2006)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma
S Fukata et al.
CANCER (2005)
Adenoviruses for treatment of cancer
A Kanerva et al.
ANNALS OF MEDICINE (2005)
Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus
A Kanerva et al.
GENE THERAPY (2005)
A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma
A Kanerva et al.
GENE THERAPY (2004)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
Different roles of ERK and p38 MAP kinases during tube formation from endothelial cells cultured in 3-dimensional collagen matrices
BH Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus
A Kanerva et al.
MOLECULAR THERAPY (2003)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy
SD Barker et al.
JOURNAL OF GENE MEDICINE (2003)
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors
R Alemany et al.
GENE THERAPY (2001)
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region
LK Hawkins et al.
GENE THERAPY (2001)
Evidence for the involvement of diacylglycerol. kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension
J Aragonés et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
C Heise et al.
NATURE MEDICINE (2000)
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri et al.
NATURE MEDICINE (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
分享论文
